rdf:type |
|
lifeskim:mentions |
umls-concept:C0021081,
umls-concept:C0085295,
umls-concept:C0086860,
umls-concept:C0087111,
umls-concept:C0205373,
umls-concept:C0242602,
umls-concept:C0332281,
umls-concept:C0449259,
umls-concept:C0678951,
umls-concept:C0867389,
umls-concept:C1515895,
umls-concept:C2745955
|
pubmed:issue |
11
|
pubmed:dateCreated |
2005-6-7
|
pubmed:abstractText |
The current study attempted to evaluate the association between IL-10 promoter gene polymorphism and transplant outcomes including the occurrence of chronic graft-versus-host disease (GVHD) and its clinical course during systemic immunosuppressive treatment (IST) among 60 recipients of cytokine-mobilized peripheral blood stem cell (PBSC) from HLA-matched sibling donors.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0041-1337
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1615-22
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15940053-Adolescent,
pubmed-meshheading:15940053-Adult,
pubmed-meshheading:15940053-Base Sequence,
pubmed-meshheading:15940053-Female,
pubmed-meshheading:15940053-Graft vs Host Disease,
pubmed-meshheading:15940053-Humans,
pubmed-meshheading:15940053-Immunosuppressive Agents,
pubmed-meshheading:15940053-Interleukin-10,
pubmed-meshheading:15940053-Lymphocyte Transfusion,
pubmed-meshheading:15940053-Male,
pubmed-meshheading:15940053-Middle Aged,
pubmed-meshheading:15940053-Polymorphism, Single Nucleotide,
pubmed-meshheading:15940053-Promoter Regions, Genetic,
pubmed-meshheading:15940053-Retrospective Studies,
pubmed-meshheading:15940053-Stem Cell Transplantation,
pubmed-meshheading:15940053-Transplantation, Homologous,
pubmed-meshheading:15940053-Transplantation Conditioning
|
pubmed:year |
2005
|
pubmed:articleTitle |
IL-10 promoter gene polymorphism associated with the occurrence of chronic GVHD and its clinical course during systemic immunosuppressive treatment for chronic GVHD after allogeneic peripheral blood stem cell transplantation.
|
pubmed:affiliation |
Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu 700-721, Korea.
|
pubmed:publicationType |
Journal Article
|